Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

US Patent 7504479 · Granted Mar 17, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitor2024
Vaccine to pathogenic immune activation cells during infections2024
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therap2022
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof2021
Vaccine to pathogenic immune activation cells during infections2021
Vaccine to pathogenic immune activation cells during infections2020
Anti-IL-6 vaccine composition2019
Method for treating chronic colitis and systemic sclerosis and for eliciting a p2017
Method of vaccination for limiting articular inflammation in rheumatoid arthriti2016
Benzenesulfon amide-compound treatment of a pathological condition linked to an 2015
Stable immunogenic product comprising antigenic heterocomplexes2014
High-yield method for the production of human antibodies blocking the biological2014